Baker Bros. Advisors 13F Filings

Review quarterly 13F filings for Baker Bros. Advisors.

Quarterly Filings

Reporting periodFiled
2026-06-302026-08-14
2026-03-312026-05-15
2025-12-312026-02-17
2025-09-302025-11-14
2025-06-302025-08-14
2025-03-312025-05-15
2024-12-312025-02-14
2024-09-302024-11-14
2024-06-302024-08-14
2024-03-312024-05-15
2023-12-312024-02-14
2023-09-302023-11-14
2023-06-302023-08-14
2023-03-312023-05-15
2022-12-312023-02-14
2022-09-302022-11-14
2022-06-302022-08-15
2022-03-312022-05-16
2021-12-312022-02-14
2021-09-302021-11-15

Latest Reported Holdings

CompanyTickerReported value
Incyte CorporationINCY3487217729
BeOne Medicines Ltd.ONC2508182548
Revolution Medicines, Inc.RVMD2143111899
Madrigal Pharmaceuticals, Inc.MDGL1150754190
ACADIA Pharmaceuticals Inc.ACAD1085696471
Kymera Therapeutics, Inc.KYMR992725940
Insmed IncorporatedIM8N937841355
Celcuity Inc.CELC828150159
Kodiak Sciences Inc.KOD776051487
Rhythm Pharmaceuticals, Inc.RYTM622265747
Praxis Precision Medicines, Inc.PRAX586953158
Alkermes plc—524592729
Summit Therapeutics Inc.SMMT477697090
GRAIL, Inc.GRAL275033478
AbCellera Biologics Inc.ABCL259145283
Immunovant, Inc.IMVT209419027
IDEAYA Biosciences, Inc.IDYA186723818
Kiniksa Pharmaceuticals International, plc—181275420
Roivant Sciences Ltd.—166928649
Arrowhead Pharmaceuticals, Inc.ARWR162431742

Browse all 13F funds